Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 2,751–2,775 of 7,816 matching trials · page 111 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
CERebrolysin In CADASIL NCT05755997 Cerebrolysin; 0.9 % NaCl Runs in: Czechia · 1 site |
PHASE2 other |
ACTIVE_NOT_RECRUITING | 30 | Ever Neuro Pharma GmbH INDUSTRY |
2025-02-25 |
|
Fundus Camera Module for Early Detection of Alzheimer's Disease NCT06841848 Fundoscopic Exam Runs in: Italy · 1 site |
NA other |
RECRUITING | 80 | I.R.C.C.S. Fondazione Santa Lucia OTHER |
2025-02-24 |
|
Biomarkers in a Candian Memory Clinic NCT06843109 Runs in: Canada · 1 site |
NA other |
ENROLLING_BY_INVITATION | 100 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's OTHER |
2025-02-24 |
|
SYNchronizing Exercises, Remedies in GaIt and Cognition NCT02808676 Vitamin D3; Exercises (E); Cognitive Training (CT); placebo D3; con... Runs in: Canada · 6 sites |
NA other |
TERMINATED | 175 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's OTHER |
2025-02-21 |
|
Advancing Understanding of Transportation Options NCT04141891 Driving Decision Aid; Older Drivers Website Runs in: United States · 3 sites |
NA other |
COMPLETED | 529 | University of Colorado, Denver OTHER |
2025-02-21 |
|
A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205 NCT04241068 Aducanumab Runs in: Australia; Austria; Belgium; Canada; Denmark; Finland; Fr... · 297 sites |
PHASE3 anti-amyloid-antibody |
TERMINATED | 1,696 | Biogen INDUSTRY |
2025-02-21 |
|
Role of Brain Specific Biomarkers in Hydrocephalus NCT06083233 Lumbar puncture; External lumbar drainage; Ventriculo-peritoneal sh... Runs in: Czechia · 1 site |
NA other |
COMPLETED | 32 | University Hospital Hradec Kralove OTHER |
2025-02-21 |
|
Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial NCT06093126 Lemborexant 5 MG Runs in: Canada · 1 site |
PHASE4 other |
RECRUITING | 1 | Nova Scotia Health Authority OTHER |
2025-02-21 |
|
The Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Mild to Moderate Alzheimer's Disease NCT06840054 Sodium Pentaborate Pentahydrate; Placebo |
PHASE2 other |
NOT_YET_RECRUITING | 30 | Tabriz University of Medical Sciences OTHER |
2025-02-21 |
|
Quality Improvement PrecivityAD Clinician Survey (QUIP I) NCT05477056 PrecivityAD blood test Runs in: United States · 1 site |
NA other |
COMPLETED | 366 | C2N Diagnostics INDUSTRY |
2025-02-20 |
|
A rTMS and Virtual Reality Based Cognitive Rehabilitation Program for MCI NCT06024473 rTMS; rTMS+iVCT Runs in: United States · 1 site |
NA other |
RECRUITING | 50 | Central Arkansas Veterans Healthcare System OTHER_GOV |
2025-02-20 |
|
Rivastigmine Mini-Tablet for Alzheimer's Disease NCT06828289 Rivastigmine Mini-Tablet; Donepezil Hydrochloride |
NA symptomatic-cholinergic |
NOT_YET_RECRUITING | 1,000 | Peking University First Hospital OTHER |
2025-02-20 |
|
A Longitudinal Study to Explore the Impact of Gut Microbiome on Brain Health in Alzheimer's Disease NCT06837272 Multi-omics features extraction Runs in: China · 1 site |
NA other |
RECRUITING | 285 | Jining Medical University OTHER |
2025-02-20 |
|
Using Immersive Virtual Reality for Cognitive Therapy in Elderly with Mild Cognitive Impairment NCT06838494 IVR-CST (Immersive Virtual Reality Cognitive Stimulation Therapy); ... Runs in: Hong Kong · 1 site |
NA other |
NOT_YET_RECRUITING | 66 | The Hong Kong Polytechnic University OTHER |
2025-02-20 |
|
TeamBaby - Safe, Digitally Supported Communication in Obstetrics and Gynecology NCT03855735 TeamBaby Online Communication Training (IG1) and TeamBaby Web-App C... Runs in: Germany · 2 sites |
NA other |
COMPLETED | 424 | Jacobs University Bremen gGmbH OTHER |
2025-02-19 |
|
Detecting an MCI and Amyloid Digital Neuro Signature(DNS) Using Altoida's Multimodal Digital Biomarkers. NCT06223438 Runs in: United States · 1 site |
NA other |
COMPLETED | 614 | Altoida INDUSTRY |
2025-02-19 |
|
Study to Evaluate a Potential PET Radioligand for Imaging Alpha-synuclein Deposits in the Brain NCT06445465 [18F]MNI-1216 Runs in: United States · 1 site |
EARLY_PHASE1 other |
COMPLETED | 12 | Invicro OTHER |
2025-02-19 |
|
AI-Driven Cognitive Digital Therapeutics for Dementia Management NCT06783465 Digital therapeutics session Runs in: Taiwan · 1 site |
NA other |
UNKNOWN | 30 | Taipei Medical University WanFang Hospital OTHER |
2025-02-19 |
|
[18F]AV45(Aβ) and [18F]AV1451(Tau)PET/CT in the Diagnosis of Early Pathological Changes of Alzheimer's Disease NCT06833645 molecular probe [18F]AV45(Aβ) and [18F]AV1451(Tau) Runs in: China · 1 site |
NA other |
RECRUITING | 280 | Sichuan Provincial People's Hospital OTHER |
2025-02-19 |
|
Tetra PICASSO AD Trial: Study to Evaluate Effects of BPN14770 in Early Alzheimer's Subjects NCT03817684 BPN14770; Placebo Runs in: United States · 41 sites |
PHASE2 other |
COMPLETED | 255 | Tetra Discovery Partners INDUSTRY |
2025-02-18 |
|
11C-PIB PET Study in MESA at Columbia University NCT03981380 11C-PIB Runs in: United States · 1 site |
NA other |
COMPLETED | 59 | José A. Luchsinger OTHER |
2025-02-18 |
|
Exercise From Afar: Progressing At Risk Individuals to Independent Exercise NCT06667817 Exercise Runs in: United States · 1 site |
NA other |
RECRUITING | 50 | Emporia State University OTHER |
2025-02-18 |
|
Lifestyle Intervention in the Memory Clinics of General and Academic Hospitals Trial NCT06832761 Personalized lifestyle intervention Runs in: Netherlands · 2 sites |
NA other |
RECRUITING | 300 | Maastricht University Medical Center OTHER |
2025-02-18 |
|
Long-term Follow-up of Cognitive and Functional Evolutions of Persons With Isolated Cognitive Complaints or Mild Cognitive Deficits NCT04111211 Runs in: France · 26 sites |
NA other |
COMPLETED | 1,028 | University Hospital, Bordeaux OTHER |
2025-02-17 |
|
Home Sleep Therapy for Older Adults With MCI NCT05771844 Transcranial Electrical Stimulation Runs in: United States · 2 sites |
NA other |
RECRUITING | 60 | Brain Electrophysiology Laboratory Company INDUSTRY |
2025-02-17 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial